John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOVA
326
DELISTED
Sunnova Energy
NOVA
| $22.6M | 0.06% |
500,399
+182,799
| +58% | +$6.34M |
|
|
HUYA
327
Huya Inc
HUYA
$498M
| $22.5M | 0.06% |
1,127,175
+779,572
| +224% | +$16.7M |
|
328
Qiagen
QGEN
$9.1B
| $22.5M | 0.06% |
400,730
-371,125
| -48% | -$19.8M |
|
329
Genpact
G
$6.24B
| $22.4M | 0.06% |
540,824
+453,497
| +519% | +$17.9M |
|
|
HOME
330
DELISTED
At Home Group Inc.
HOME
| $22.3M | 0.06% |
1,443,364
-84,963
| -6% | -$1.48M |
|
|
CSOD
331
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $22.3M | 0.06% |
506,254
-58,691
| -10% | -$2.43M |
|
332
Ovintiv
OVV
$18.5B
| $22.1M | 0.06% |
1,541,604
+967,504
| +169% | +$11.3M |
|
333
Denali Therapeutics
DNLI
$3.98B
| $21.9M | 0.06% |
261,070
+70,025
| +37% | +$4.23M |
|
334
Illumina
ILMN
$33.1B
| $21.7M | 0.06% |
60,415
+57,310
| +1,846% | +$18.3M |
|
335
Invesco
IVZ
$14.1B
| $21.7M | 0.06% |
1,246,752
+464,759
| +59% | +$7.15M |
|
336
TFI International
TFII
$11.6B
| $21.6M | 0.06% |
418,248
-79,915
| -16% | -$3.97M |
|
337
PUT
Twilio
TWLO
$34.6B
| $21.5M | 0.06% |
63,500
-92,500
| -59% | -$28.9M |
|
338
Gaming and Leisure Properties
GLPI
$12.7B
| $21.4M | 0.06% |
504,851
+153,643
| +44% | +$6.2M |
|
339
Exelon
EXC
$45.1B
| $21.4M | 0.06% |
710,508
-2,269,280
| -76% | -$67M |
|
|
VAR
340
DELISTED
Varian Medical Systems, Inc.
VAR
| $21.4M | 0.06% |
122,192
+117,424
| +2,463% | +$20.4M |
|
341
Avis
CAR
$5.18B
| $21.3M | 0.06% |
570,973
-295,781
| -34% | -$10.4M |
|
342
NVR
NVR
$16.9B
| $21.3M | 0.06% |
5,213
-117
| -2% | -$486K |
|
343
Huntington Ingalls Industries
HII
$11.8B
| $21.2M | 0.06% |
124,627
-60,391
| -33% | -$9.6M |
|
344
LendingTree
TREE
$433M
| $21.2M | 0.06% |
77,556
+14,922
| +24% | +$4.43M |
|
345
H&R Block
HRB
$6.62B
| $21.2M | 0.06% |
1,336,571
-756,622
| -36% | -$13.1M |
|
346
Louisiana-Pacific
LPX
$5.12B
| $21.2M | 0.06% |
569,850
+113,037
| +25% | +$3.79M |
|
347
Mondelez International
MDLZ
$82.3B
| $21.1M | 0.06% |
+361,010
| New | +$20.6M |
|
348
JetBlue
JBLU
$1.85B
| $21.1M | 0.06% |
1,450,841
+78,918
| +6% | +$1.08M |
|
349
PUT
Sea Limited
SE
$72B
| $21.1M | 0.06% |
105,800
-35,900
| -25% | -$6.39M |
|
|
XYZ
350
CALL
Block Inc
XYZ
$49.4B
| $21M | 0.06% |
96,600
-6,600
| -6% | -$1.29M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.